Lupin submits copy of additional clarification

30 Mar 2016 Evaluate

With reference to the news flashed on CNBC TV 18 ‘Mandideep unit inspected by US FDA from 8-19 Feb 2016. US FDA observations at Mandideep unit are serious in nature and the unit gets 483 letter’, Lupin has submitted a copy of additional Clarification.

The above information is a part of company’s filings submitted to BSE.

Lupin Share Price

2163.00 -15.20 (-0.70%)
20-Jan-2026 12:30 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1639.70
Dr. Reddys Lab 1184.30
Cipla 1378.30
Zydus Lifesciences 875.05
Lupin 2163.00
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×